India Post News Paper

 Breaking News

WHO to raise $31.3 billion against Covid-19

WHO to raise $31.3 billion against Covid-19
June 27
11:47 2020

GENEVA: The World Health Organization (WHO) has said the WHO-led global response to Covid-19 needs $31.3 billion for therapeutics, vaccines and diagnostics over the next 12 months, including two billion doses of vaccines.

The money would go to the Access to Covid-19 Tools Accelerator, or ACT-Accelerator, a global collaboration initiated in April to accelerate development, production, and equitable access to Covid-19 tests, treatments, and vaccines. Xinhua reported.

The WHO said on Friday some $3.4 billion has been contributed to date, resulting in a funding gap of $27.9 billion, of which $13.7 billion of the remaining gap is urgently needed. It plans to scale up delivery of 500 million tests and 245 million courses of treatments to low- and middle-income countries (LMICs) by mid-2021, as well as two billion vaccine doses, of which one billion to be purchased for LMICs, by the end of 2021.

“The investment required is significant, but it pales in significance when compared to the cost of Covid-19,” said WHO in a statement, adding that the total cost of the ACT-Accelerator’s work is less than a tenth of what the International Monetary Fund estimates the global economy is losing every month due to the pandemic.

The ACT-Accelerator is led by the work of WHO’s partner organizations collaborating under four pillars, including diagnostics, therapeutics, vaccines and the health systems connector. The vaccine pillar, with the combination of the Coalition for Epidemic Preparedness Innovations (CEPI) and Gavi, the Vaccine Alliance, has the estimate that it will cost up to 18.1 billion dollars to deliver two billion doses by the end of 2021. In addition, 950 million doses will need to be procured by self-financing high-income countries and upper middle-income countries.

“The good news is we have over 200 vaccine candidates at some stage of clinical development, 15 of them are now on human clinical trials,” said WHO Chief Scientist Soumya Swaminathan at the press briefing of the organization on Friday.

According to her, at least four Chinese companies are ready going from phase two to phase three trails for vaccine candidates and the WHO is in the process of exchanging documents, signing confidentiality agreement with them in order to provide advice and support, and facilitate conduct of clinical trials.

Comments

comments

Related Articles

    Polls

    Should India Stop all the Aid to Nepal?

    Loading ... Loading ...

    E-paper Latest Edition

    ADVERTISEMENT – DAFABET ESPORTS

    Dafabet Gaming Portal

    ADVERTISEMENT – NRIA NET

    www.nria.net

    ADVERTISEMENT – DR HORTON

    Dr Horton Skyline Ridge

    ADVERTISEMENT – SEVEN JACKPOTS

    casino

    ADVERTISEMENT – BETRALLY INDIA

    betting India

    ADVERTISEMENT – DR HORTON

    ADVERTISEMENT – Star Tours

    Star Tours

    50 SPIRITUAL APPETIZERS – VINOD DHAWAN

    50-ad-Indiapost

    It’s a lovely book. It feels energetically clear and light. It’s easy to read, dip in and out and most importantly it offers information without fluff! Blessings on this project.

    Jac O’Keeffe
    Spirituality teacher based in USA.

    *Available on Amazon, Flipkart & other online stores*

    ADVERTISEMENT – JOBSORA- FIND A JOB NOW!

    Jobsora Jobs

    Follow us On Twitter

    RT @ZeeNewsEnglish: Nagaland bans sale of dog meat after outcry on social media https://t.co/BkRRmb6jte
    h J R
    RT @ndtv: #BigFight | Brahma Chellaney, Strategic Affairs Expert on India-China border tension https://t.co/lcoZQnHi3U
    h J R
    RT @ANI: Earthquake tremors felt in Delhi. https://t.co/asAxQGc1aF
    h J R
    RT @ANI: Pained by the tragic demise of Sikh pilgrims in Pakistan. My thoughts are with their families and friends in this hour of grief. I…
    h J R

    POPULAR CATEGORIES

    Download Media Kit

    India Post Media Kit